Biolase (BIOL) Reports Q1 Loss of $0.06

Biolase (NASDAQ: BIOL) reported Q1 EPS of ($0.06), versus ($0.07) reported last year. Revenue for the quarter came in at $10.9 million versus the consensus estimate of $13.23 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Reading (RDI) Tops Q2 EPS by 4c
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c